Where does Myriad Medical LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Myriad Medical LLC ranks #48,922 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Myriad Medical LLC hold?

Myriad Medical LLC holds 5 US utility patents granted between 2017 and 2021, spanning 2 technology areas.

What is Myriad Medical LLC's Innovation Score?

Myriad Medical LLC has an Innovation Score of 16.7 out of 100 (4th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Myriad Medical LLC's patent grant rate increasing or decreasing?

Myriad Medical LLC's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Myriad Medical LLC's patents?

Myriad Medical LLC's patents average 9.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Myriad Medical LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Myriad Medical LLC

Q: What technology areas does Myriad Medical LLC focus on?

Myriad Medical LLC's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 5 patents, ranking #1,311 of 3,490 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2017–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Myriad ranks #48,922 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.

#48,922
of 49,997 US assignees by volume: 4th percentile
by Innovation Score (16.7/100): 9.2
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R48922 · US Corporation #48,922 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,922/49,997
PHOTO-FINISH Müller Martini Holding
CPC-NARROW A61M · 2 areas
INNOV-LOW 16.7/100
CLAIMS-PAR 9.2 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Müller Martini Holding AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Myriad’s 16.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (37%) Velocity 0.0 pts (0%) Breadth 5.0 pts (30%) Claim depth 5.5 pts (33%)

Qualcomm Incorporated · highest

85
Myriad Medical · this assignee

17
3D Lighting… · lowest

7

What this shows Myriad's Innovation Score is 16.7/100 (4th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Myriad?

Each dot is one of Myriad’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Myriad’s own 9.2 claims/patent is at or below the 19.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Myriad vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Myriad's grants concentrate

Myriad Medical LLC is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2017. By volume, Myriad sits between MyMD Pharmaceuticals (Florida), Inc. and NAD Grid Corp.

Mymd Pharmaceutic…

5
Myabuy

5
Mylar Specialty F…

5
Myomo

5
Müller Martini Ho…

5
N B Adventures

5
Desmet Ballestra…

5
NAD Grid

5
Myriad Medical ◀

5

What this shows Myriad holds 5 patents at rank #48,928, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Myriad

By rank, the assignees closest to #48,928 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Myriad's primary technology class.

Myriad's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

17 4th percentile higher than 4% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Myriad Medical LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	20.0%
2019	1	20.0%
2020	1	20.0%
2021	2	40.0%

Which technologies does Myriad Medical LLC patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 5

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Myriad Medical LLC's patent record in context - here's where to go next.

Myriad Medical LLC's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 100% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #48,922 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Myriad Medical LLC against MyMD Pharmaceuticals (Florida), Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 16.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.